DUBLIN–(BUSINESS WIRE)–The “Ketolides Global Market Report 2024” report has been added to ResearchAndMarkets.com’s offering.
The global ketolides market is poised for steady expansion, driven by the growing need for effective treatments for infectious diseases and an upsurge in healthcare investments. According to the latest market research report, the ketolides market showcases a promising compound annual growth rate (CAGR), signaling a positive trajectory from $3.07 billion in 2023 to a projected value of $3.82 billion by 2028.
With North America leading the sector, the report highlights pivotal factors contributing to market growth, including increased chronic sinusitis cases, enhanced tuberculosis management, and burgeoning awareness of antimicrobial stewardship. It also identifies emerging trends in targeted therapies and advancements in diagnostic procedures that are augmenting the ketolides market landscape.
The ketolides market benefits from the substantial presence of major pharmaceutical companies focusing on innovative antibiotic formulations. These entities, through their significant R&D efforts, are addressing the urgent need for new treatments amidst escalating infectious diseases prevalence worldwide.
Notable Growth in the North American Ketolides Sector
The report underscores North America’s dominance in the ketolides arena, attributable to robust healthcare infrastructure, comprehensive screening programs, and a heightened focus on infectious disease control. The region’s capacity to innovate and swiftly implement novel treatments bolsters its position as the market leader.
Despite promising progress, the market faces challenges, including the side effects associated with ketolide usage. Addressing these concerns is paramount for ketolides to maintain their critical role in the antibiotic therapy landscape.
The report analyzes the ketolides market segmentation, considering key drug classes like telithromycin, cethromycin, and solithromycin. It delves into their applications across various bacterial infections, such as respiratory tract infections, and their distribution through hospitals, retail, and online pharmacies.
- Prevailing infectious diseases continue to drive ketolide demand
- Ketolide advancements offer new therapies for infectious disease management
- Side effects of ketolides present manageable challenges to the market
For more information about this report visit https://www.researchandmarkets.com/r/v5lzfe
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900